ArticleCureus2025
Creutzfeldt-Jakob Disease: Insights from a Case Report and Diagnostic Challenges.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Creutzfeldt-Jakob disease (CJD) is a rare, rapidly progressive, and fatal neurodegenerative disorder caused by abnormal prion proteins. Due to its often nonspecific and variable early symptoms, CJD is frequently misdiagnosed as a psychiatric or other neurodegenerative condition, creating significant diagnostic challenges. Timely recognition is crucial but remains difficult due to its rarity and overlap with more common disorders. We describe a 66-year-old male patient who was initially admitted to a psychiatric unit with prominent behavioral disturbances and mood changes. The clinical presentation was initially attributed to a primary psychiatric illness, particularly bipolar disorder. Brain imaging and electroencephalogram (EEG) were inconclusive. However, cerebrospinal fluid (CSF) analysis revealed findings consistent with prion disease, confirming the diagnosis of CJD. The patient's neurological function deteriorated rapidly, and he died within two months of diagnosis. This case highlights the diagnostic complexity of CJD, especially in its early stages when psychiatric symptoms may predominate. A high index of suspicion and early use of CSF biomarkers are essential for timely diagnosis. Clinicians should consider CJD in the differential diagnosis of rapidly progressive neuropsychiatric syndromes, as early recognition, although not curative, can guide appropriate care and family counseling.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.